These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

246 related items for PubMed ID: 9596953

  • 21. [Akt gene therapy for cirrhotic rats with portal hypertension].
    Huang FZ, Deng G, Liu XY, Luo CQ.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Jan; 33(1):31-7. PubMed ID: 18245901
    [Abstract] [Full Text] [Related]

  • 22. [Architectural changes of the blood vessels in the hepatic lobules and reorganization of the walls of the portal vein, hepatic artery and hepatic vein in experimental portal hypertension].
    Kapustina EV.
    Arkh Anat Gistol Embriol; 1968 Jan; 55(8):91-100. PubMed ID: 5685073
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Neutral endopeptidase (EC 3.4.24.11) in cirrhotic liver: a new target to treat portal hypertension?
    Sansoè G, Aragno M, Mastrocola R, Restivo F, Mengozzi G, Smedile A, Rosina F, Danni O, Parola M, Rizzetto M.
    J Hepatol; 2005 Nov; 43(5):791-8. PubMed ID: 16085334
    [Abstract] [Full Text] [Related]

  • 26. The hepatic microcirculation in the isolated perfused human liver.
    Villeneuve JP, Dagenais M, Huet PM, Roy A, Lapointe R, Marleau D.
    Hepatology; 1996 Jan; 23(1):24-31. PubMed ID: 8550044
    [Abstract] [Full Text] [Related]

  • 27. Role of beta3-adrenoceptors for intrahepatic resistance and portal hypertension in liver cirrhosis.
    Trebicka J, Hennenberg M, Schulze Pröbsting A, Laleman W, Klein S, Granzow M, Nevens F, Zaagsma J, Heller J, Sauerbruch T.
    Hepatology; 2009 Dec; 50(6):1924-35. PubMed ID: 19842096
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Transarterial ethanol ablation of cirrhotic liver with lipiodol-ethanol mixture: safety and efficacy study in rats.
    Yu SC, Chan CT.
    Invest Radiol; 2006 Aug; 41(8):609-17. PubMed ID: 16829743
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. A stable model of cirrhotic portal hypertension in the rat: thioacetamide revisited.
    Laleman W, Vander Elst I, Zeegers M, Servaes R, Libbrecht L, Roskams T, Fevery J, Nevens F.
    Eur J Clin Invest; 2006 Apr; 36(4):242-9. PubMed ID: 16620286
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Ablation of primary afferent neurons by neonatal capsaicin treatment reduces the susceptibility of the portal hypertensive gastric mucosa to ethanol-induced injury in cirrhotic rats.
    Camara PR, Ferraz GJ, Franco-Penteado CF, Sbragia-Neto L, Meirelles LR, Teixeira SA, Muscara MN, Velloso LA, Antunes E, Ferraz JG.
    Eur J Pharmacol; 2008 Jul 28; 589(1-3):245-50. PubMed ID: 18555214
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.